Comorbid conditions in psoriasis

Brynina, A. V.; Gimhan, D. R.; Wickramage, A. I.

dc.contributor.author	Brynina, A. V.
dc.contributor.author	Gimhan, D. R.
dc.contributor.author	Wickramage, A. I.
dc.date.accessioned	2023-03-14T08:45:33Z
dc.date.available	2023-03-14T08:45:33Z
dc.date.issued	2023
dc.identifier.citation	Brynina, A.V. Comorbid conditions in psoriasis / A. V. Brynina, D. R. Gimhan, A. I. Wickramage // Journal of the Grodno State Medical University. 2023;21(1):12-18. – doi: 10.25298/2221-8785-2023-21-1-12-18.	ru_RU
dc.identifier.issn	2221-8785
dc.identifier.uri	http://elib.grsmu.by/handle/files/29362
dc.description	psoriasis, comorbidity, combined pathology, cardiovascular diseases, endocrine pathology, gout, inflammatory bowel diseases	ru_RU
dc.description.abstract	Psoriasis is a chronic dermatosis of a multifactorial nature with a dominant role in the development of genetic factors, characterized by hyperproliferation of epidermal cells, impaired keratinization, and inflammation in the dermis. Currently, its prevalence in the population is from 0.1 to 7%, and among people hospitalized in dermatological hospitals – from 25 to 40%. In the scientific literature, the issue of considering psoriasis as a systemic disease is widely discussed, which includes damage not only to the skin, but also to other organs and systems. Thus, the indicated problems of combined pathology are relevant, require further in-depth study and search for evidence-based solutions that will improve the quality of medical care for patients with both psoriasis alone and its combined course.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	ГрГМУ	ru_RU
dc.title	Comorbid conditions in psoriasis	ru_RU
dc.type	Article	ru_RU